Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by AngioDynamics, Inc.

AngioDynamics to Report Fiscal 2024 First Quarter Financial Results on October 4, 2023
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Completes Enrollment for PRESERVE Clinical Study
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Participate in a Fireside Chat at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Announces Addition of Lorinda Burgess to Board of Directors
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal Year 2023 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2024 Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2023 Fourth Quarter and Full-Year Financial Results on July 12, 2023
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Announces Sale of Dialysis Product Portfolio and BioSentry Product to Merit Medical Systems for $100 Million
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal 2023 Third Quarter Financial Results; Revises Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2023 Third Quarter Financial Results on March 30, 2023
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Participate in Three Investor Conferences in March
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal 2023 Second Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2023 Second Quarter Financial Results on January 5, 2023
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the Piper Sandler Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Announces First Patient Enrolled in APEX-AV Study Assessing AlphaVac F1885 PE System in Treatment of Pulmonary Embolism
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal 2023 First Quarter Financial Results; Reaffirms Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2023 First Quarter Financial Results on October 6, 2022
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the Canaccord Genuity Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the UBS Global Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the BofA Securities Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the Needham Virtual Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
AngioDynamics to Present at the Needham Virtual Growth Conference
From AngioDynamics, Inc.
Via Business Wire
Tickers ANGO
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.